Literature DB >> 10598823

Streptozotocin-diabetes impairs prolactin binding to Leydig cells in prepubertal and pubertal rats.

S Sudha1, B R Sankar, G Valli, P Govindarajulu, K Balasubramanian.   

Abstract

Prolactin (PRL) binding to Leydig cells in prepubertal and pubertal streptozotocin (STZ)-diabetic and insulin-treated rats was studied. Prepubertal (30-day-old) and pubertal (50-day-old) rats were made diabetic by single injection of STZ (120 and 100 mg/kg b.wt, respectively). After 3 days of STZ administration, a group of rats was given insulin injections subcutaneously (3 U/100 g b.wt/day in 2 equally divided doses). Animals of prepubertal and pubertal groups were killed on postnatal days 51 and 71, respectively. Age-dependent increase in serum testosterone, PRL levels and PRL receptors on Leydig cells were prevented by STZ-diabetes. Insulin administration partly or completely prevented these changes. These results suggest that steroidogenic defects in Leydig cells of prepubertal and pubertal diabetic rats may be associated with decrease in serum PRL levels and its receptors on Leydig cells. Insulin probably has a role in the maintenance of PRL receptor numbers on Leydig cells during pubertal maturation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598823     DOI: 10.1055/s-2007-978800

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

1.  Effects of prolactin on ventricular myocyte shortening and calcium transport in the streptozotocin-induced diabetic rat.

Authors:  Frank C Howarth; Gunnar Norstedt; Oleksiy I Boldyriev; Muhammad A Qureshi; Ozaz Mohamed; Khatija Parekh; Balaji Venkataraman; Sandeep Subramanya; Anatoliy Shmygol; Lina T Al Kury
Journal:  Heliyon       Date:  2020-04-18

2.  Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model.

Authors:  Kuan-Chou Chen; Shian-Ying Sung; Yi-Ting Lin; Chiu-Lan Hsieh; Kun-Hung Shen; Chiung-Chi Peng; Robert Y Peng
Journal:  BMC Urol       Date:  2015-11-17       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.